475 related articles for article (PubMed ID: 20719222)
1. What can surveillance of genital warts tell us?
Fairley CK; Donovan B
Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
[TBL] [Abstract][Full Text] [Related]
2. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
3. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
[TBL] [Abstract][Full Text] [Related]
4. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
[TBL] [Abstract][Full Text] [Related]
5. HPV vaccine and its recommendations, 2007.
Zimmerman RK
J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S1-5, C1. PubMed ID: 17270106
[TBL] [Abstract][Full Text] [Related]
6. Developing an HPV vaccine to prevent cervical cancer and genital warts.
Bryan JT
Vaccine; 2007 Apr; 25(16):3001-6. PubMed ID: 17289220
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus vaccines: an update for gynecologists.
Ault KA
Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
[TBL] [Abstract][Full Text] [Related]
8. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
[TBL] [Abstract][Full Text] [Related]
9. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
Oliphant J; Perkins N
N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
11. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
Perkins RB; Legler A; Hanchate A
Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.
Haupt RM; Sings HL
J Adolesc Health; 2011 Nov; 49(5):467-75. PubMed ID: 22018560
[TBL] [Abstract][Full Text] [Related]
13. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
[TBL] [Abstract][Full Text] [Related]
14. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
Juraskova I; Bari RA; O'Brien MT; McCaffery KJ
Womens Health Issues; 2011; 21(1):71-9. PubMed ID: 21185992
[TBL] [Abstract][Full Text] [Related]
15. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.
Dunne EF; Friedman A; Datta SD; Markowitz LE; Workowski KA
Clin Infect Dis; 2011 Dec; 53 Suppl 3():S143-52. PubMed ID: 22080267
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
Brotherton JM; Kaldor JM; Garland SM
Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
[TBL] [Abstract][Full Text] [Related]
17. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
Dunne EF; Datta SD; E Markowitz L
Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
[TBL] [Abstract][Full Text] [Related]
18. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
[TBL] [Abstract][Full Text] [Related]
19. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
20. [Human papillomavirus vaccination. Consensus Conference in pediatric age].
Bartolozzi G; Bona G; Ciofi M; De Martino M; Di Pietro P; Duse M; Esposito S; Gasparini R; Mariani L; Marostica G; Paravati F; Plebani A; Principi N; Zuccotti GV; Tovo PA
Minerva Pediatr; 2007 Jun; 59(3):165-82. PubMed ID: 17519861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
